Breast Cancer Research and Treatment

Rab11a Differentially Modulates Epidermal Growth Factor-induced Proliferation and Motility in Immortal Breast Cells
pp. 127-137(11)
Authors: Palmieri, Diane; Bouadis, Amina; Ronchetti, Ruban; Merino, Maria; Steeg, Patricia

E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis
pp. 139-148(10)
Authors: Gould Rothberg, Bonnie; Bracken, Michael

Advanced breast cancer: anti-progressive immunotherapy using a thermostable autologous hemoderivative
pp. 149-160(12)
Authors: Lasalvia-Prisco, Eduardo; Vázquez, Jesús; Golomar, Wilson; Larrañaga, Joshemaria; Garcia-Giralt, Emilio; Cucchi, Silvia; Lasalvia-Galante, Eduardo

Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival
pp. 161-167(7)
Authors: Kostadima, L.; Pentheroudakis, G.; Fountzilas, G.; Dimopoulos, M.; Pectasides, D.; Gogas, H.; Christodoulou, C.; Samantas, E.; Bafaloukos, D.; Arapantoni, P.; Kalofonos, H.; Papakostas, P.; Economopoulos, T.; Bamias, A.; Pavlidis, N.; Stropp, U.; Wirtz, R.; Hennig, G.

Association of GSTP1 CpG Islands Hypermethylation with Poor Prognosis in Human Breast Cancers
pp. 169-176(8)
Authors: Arai, Takashi; Miyoshi, Yasuo; Kim, Seung; Taguchi, Tetsuya; Tamaki, Yasuhiro; Noguchi, Shinzaburo

Plasma Levels of Tamoxifen, N-Desmethyl Tamoxifen and Anastrozole in a Patient with Metastatic Breast Cancer and Chronic Hemodialysis
pp. 177-181(5)
Authors: Langenegger, T.; Wahl, P.; Schiesser, D.; Thürlimann, B.

Economic Analysis of Psychosocial Group Therapy in Women with Metastatic Breast Cancer
pp. 183-190(8)
Authors: Lemieux, Julie; Topp, Adam; Chappell, Heather; Ennis, Marguerite; Goodwin, Pamela

Psychological Distress in U.S. Women Who Have Experienced False-Positive Mammograms
pp. 191-200(10)
Authors: Jatoi, Ismail; Zhu, Kangmin; Shah, Mona; Lawrence, William

Infertility, Ovulation Induction Treatments and the Incidence of Breast Cancer—a Historical Prospective Cohort of Israeli Women
pp. 201-212(12)
Authors: Lerner-Geva, L.; Keinan-Boker, L.; Blumstein, T.; Boyko, V.; Olmar, L.; Mashiach, S.; Rabinovici, J.; Potashnik, G.; Lunenfeld, E.; Schenker, J.; Shushan, A.; Fishman, A.; Cohen, I.; Vagman, I.; Lunenfeld, B.

Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer
pp. 213-218(6)
Authors: Choi, Ji-Yeob; Lee, Kyoung-Mu; Noh, Dong-Young; Ahn, Sei-Hyun; Lee, Jong-Eun; Han, Wonshik; Jang, In-Jin; Shin, Sang-Goo; Yoo, Keun-Young; Hayes, Richard; Kang, Daehee

Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study
pp. 219-227(9)
Authors: Buettner, Catherine; Kroenke, Candyce; Phillips, Russell; Davis, Roger; Eisenberg, David; Holmes, Michelle

REporting recommendations for tumor MARKer prognostic studies (REMARK)
pp. 229-235(7)
Authors: McShane, Lisa; Altman, Douglas; Sauerbrei, Willi; Taube, Sheila; Gion, Massimo; Clark, Gary

New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK
pp. 237-238(2)
Authors: Hayes, Daniel; Ethier, Stephen; Lippman, Marc